Matrix metalloproteinase landscape in the imiquimod-induced skin inflammation mouse model
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk Foundation (NNF16OC0020670)
- LEO Foundation (LF-OC-19-000033, LF-OC-23-001220)
- leo pharma a/s
- Københavns Universitet (LF15007)
This publication has 38 references indexed in Scilit:
- Design and characterization of matrix metalloproteinase-responsive hydrogels for the treatment of inflammatory skin diseasesActa Biomaterialia, 2022
- Mouse Models of Psoriasis: A Comprehensive ReviewJournal of Investigative Dermatology, 2022
- MMP-9 Mediates Cross-Talk between Neutrophils and Endothelial Cells in PsoriasisJournal of Investigative Dermatology, 2021
- New strategies to identify protease substratesCurrent Opinion in Chemical Biology, 2021
- Matrix metalloproteinase-7 could be a predictor for acute inflammation in psoriatic patientsCytokine, 2020
- Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse modelInternational Journal of Pharmaceutics, 2019
- Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticlesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2017
- Proteases and proteomics: Cutting to the core of human skin pathologiesProteomics – Clinical Applications, 2014
- Matrix metalloproteinases and their role in psoriasisGene, 2014
- MMP-8 Is the Predominant Collagenase in Healing Wounds and Nonhealing UlcersJournal of Surgical Research, 1999